London-headquartered Vicebio has initiated a Phase I clinical trial (NCT06556147) of its bivalent vaccine VXB-241 that targets both RSV and human metapneumovirus (hMPV) viruses. The trial will ...

Both human metapneumovirus and respiratory syncytial virus (RSV) are respiratory infections that primarily affect children but can also cause severe illness in older adults. These are quite ...

Icosavax’s pipeline of respiratory disease vaccines is headed by IVX-A12, a virus-like particle (VLP) shot that targets both RSV and human metapneumovirus (hMPV), two major causes of serious ...

The causes behind the current surge in cases pertaining to respiratory illnesses are influenza virus, RSV and HMPV and this is not unusual this time of year," Reports global health experts.

HMPV has been found worldwide. Symptoms exhibited by patients are similar to those in respiratory syncytial virus-infected patients. Clinical symptoms vary, but it is a significant cause of lower ...

The causes behind the current surge in cases pertaining to respiratory illnesses are influenza virus, RSV and HMPV and this is not unusual this time of year," Reports global health experts.

HMPV stands for Human Metapneumovirus. It belongs to the Paramyxoviridae family, which includes other respiratory viruses like RSV (Respiratory Syncytial Virus). It can affect people of all age ...

HMPV, which belongs to the same family as the respiratory syncytial virus, causes flu or cold-like symptoms including fever, cough and nasal congestion. The symptoms often clear up by themselves ...

(Reuters) -British pharmaceutical giant GlaxoSmithKline and rival Pfizer have agreed to end a lawsuit that alleged Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo violated GSK's patent ...

(Background image: People wearing protective face masks as a preventive measure against the spread of HMPV in India/Right image: Prof Sarath Ranganathan, a Melbourne-based expert in respiratory ...